Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 104528074 | 10452807 | 4 | F | 201309 | 20160928 | 20140915 | 20160930 | EXP | PHHY2014MX022468 | NOVARTIS | 81.89 | YR | F | Y | 0.00000 | 20160930 | CN | COUNTRY NOT SPECIFIED | MX |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 104528074 | 10452807 | 1 | PS | CO-DIOVAN | HYDROCHLOROTHIAZIDEVALSARTAN | 1 | Oral | 0.5 DF, QD (HYDROCHLOROTHIAZIDE 12.5 MG, VALSARTAN 160 MG) | D | 20818 | .5 | DF | FILM-COATED TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 104528074 | 10452807 | 1 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 104528074 | 10452807 | DE |
| 104528074 | 10452807 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 104528074 | 10452807 | Death | |
| 104528074 | 10452807 | Drug prescribing error | |
| 104528074 | 10452807 | Fall | |
| 104528074 | 10452807 | Hip fracture | |
| 104528074 | 10452807 | Lower limb fracture | |
| 104528074 | 10452807 | Wrong technique in product usage process |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |